CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients

por Ahmed, Huda Al Sayed, Raslan, Wasim Fawzi, Deifalla, Abdel Halim Salem, Fathallah, Mohammad Dahmani
Publicado 2019